{"id":32693,"date":"2016-12-15T10:48:04","date_gmt":"2016-12-15T18:48:04","guid":{"rendered":"http:\/\/lifeboat.com\/blog\/2016\/12\/can-naked-mole-rats-teach-us-the-secrets-to-living-far-longer-google-thinks-so"},"modified":"2017-04-24T19:12:07","modified_gmt":"2017-04-25T02:12:07","slug":"can-naked-mole-rats-teach-us-the-secrets-to-living-far-longer-google-thinks-so","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2016\/12\/can-naked-mole-rats-teach-us-the-secrets-to-living-far-longer-google-thinks-so","title":{"rendered":"Can naked mole rats teach us the secrets to living far longer? Google thinks so"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/can-naked-mole-rats-teach-us-the-secrets-to-living-far-longer-google-thinks-so.jpg\"><\/a><\/p>\n<p>It is looking increasingly likely the mysterious Google Calico have very modest ambitions regarding increased lifespans for humans given the comments made by Dr. Aubrey de Grey and others and the direction they are taking with their research. Modest increases of lifespan over the kind of robust therapies of SENS seems pretty dissapointing.<\/p>\n<hr>\n<p>More about Google Calico and their aim to modestly increase lifespan. People like Dr. Aubrey de Grey and Nathaniel David from rising biotech star Unity.<\/p>\n<p>\u201cTo some, Calico\u2019s heavy bet on basic biology is a wrong turn. The company is \u201cmy biggest disappointment right now,\u201d says Aubrey de Grey, an influential proponent of attempts to intervene in the aging process and chief science officer of the SENS Research Foundation, a charity an hour\u2019s drive from Calico that promotes rejuvenation technology. It is being driven, he complains, \u201cby the assumption that we still do not understand aging well enough to have a chance to develop therapies.\u201d Indeed, some competitors are far more aggressive in pursuing interventions than Calico is.<\/p>\n<p>They are very committed to these fundamental mechanisms, and bless them for doing that. But we are committed to putting drugs into the clinic and we might do it first,\u201d says Nathaniel David, president and cofounder of Unity Biotechnology. This year, investors put $127 million behind Unity, a startup in San Francisco that\u2019s developing drugs to zap older, \u201csenescent\u201d cells that have stopped dividing. These cells are suspected of releasing cocktails of unhelpful old-age signals, and by killing them, Unity\u2019s drugs could act to rejuvenate tissues. The company plans to start with a modestly ambitious test in arthritic knees. De Grey\u2019s SENS Foundation, for its part, has funded Oisin Biotechnologies, a startup aiming to rid bodies of senescent cells using gene therapy.\u201d<\/p>\n<p><!-- Link: <a href=\"https:\/\/www.technologyreview.com\/s\/603087\/googles-long-strange-life-span-trip\/\">https:\/\/www.technologyreview.com\/s\/603087\/googles-long-strange-life-span-trip\/<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>It is looking increasingly likely the mysterious Google Calico have very modest ambitions regarding increased lifespans for humans given the comments made by Dr. Aubrey de Grey and others and the direction they are taking with their research. Modest increases of lifespan over the kind of robust therapies of SENS seems pretty dissapointing. More about [\u2026]<\/p>\n","protected":false},"author":370,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412,269],"tags":[],"class_list":["post-32693","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/32693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/370"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=32693"}],"version-history":[{"count":2,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/32693\/revisions"}],"predecessor-version":[{"id":49468,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/32693\/revisions\/49468"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=32693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=32693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=32693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}